Litts Drug Eruption & Reaction Database - Presented by CRC Press

Nothing else can remotely compare to it.Patricia Wong, MD, Stanford University Medical Centre


Log in
In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
Continue
Menu
Login
  • Home
  • About About
    • About the Database
    • About the Book
    • Related Products
    • About Dr Litt
    • About Dr Shear
  • Alerts
  • Litt’s App
  • Contact Us
  • Help
  • Subscribe Subscribe
    • Individual Subscription
    • Institutional Subscription

Drugs belonging to  restart save

class – Anticonvulsant (see also antiepileptic (anti-seizure)) – 28 items found

  • show all
  • 0–9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Brivaracetam

Carbamazepine

Cenobamate

Clobazam

Eslicarbazepine

Ezogabine

Felbamate

Gabapentin

Lacosamide

Lamotrigine

Levetiracetam

Mephenytoin

Oxcarbazepine

Perampanel

Phenacemide

Phenobarbital

Phensuximide

Phenytoin

Pregabalin

Primidone


Loading more results

No more results to show

Adverse reactions attributed to entire drug class 'Anticonvulsant (see also antiepileptic (anti-seizure))'

Please login to view adverse reactions.

Cutaneous adverse reaction (includes severe cutaneous adverse drug reaction (SCAR))

    • (2025): Ingen-Housz-Oro S+, Therapie Mar, Online ahead of print [REVIEW]
    • (2023): Spina Tensini T+, HLA Mar, Online ahead of print (pharmacogenomics)
    • (2022): Fong SL+, J Clin Pharmacol Mar, Online ahead of print
    • (2022): Martins JC+, An Bras Dermatol Apr, Online ahead of print
    • (2021): Alfares I+, CNS Drugs Feb, Online ahead of print [REVIEW]

DRESS syndrome (Drug-induced hypersensitivity syndrome)

    • (2025): Qian J+, Seizure 125, 37-43 (pharmacovigilance / pharmacoepidemiology)
    • (2012): Descamps V, Rev Prat (French) 62(10), 1347

Exanthems

    • (2015): Farshchian M+, Clin Cosmet Investig Dermatol 8, 5326%

Fibromatosis [includes palmar fibromatosis (Dupuytren's contracture / Dupuytren's disease), plantar fibromatosis (Ledderhose disease) and penile fibromatosis (Peyronie disease)]

    • (1999): Coral P+, Arq Neuropsiquiatr (Portuguese) 57(3B), 860-2 (1 case / male)
    • (1976): Critchley EM+, J Neurol Neurosurg Psychiatry 39(5), 498-503 (association)

Hypersensitivity

Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN)

    • (2021): Sivagourounadin K+, Curr Drug Saf Jun, Online ahead of print [REVIEW]
    • (2011): Barvaliya M+, J Postgrad Med 57(2), 11519%

Toxic epidermal necrolysis (Lyell's syndrome)

    • (2021): Sivagourounadin K+, Curr Drug Saf Jun, Online ahead of print [REVIEW]
    • (2011): Barvaliya M+, J Postgrad Med 57(2), 11582%

Alopecia / hair loss

    • (2023): Pitton Rissardo J+, Medicines (Basel) 10(6), 35 [REVIEW]

Neuropsychiatric / neuropsychological adverse effect

    • (2022): Bjørk MH+, JAMA Neurol 79(7), 672-681Pediatric (subsequent to pre-natal exposure to antiseizure medication)

Stuttering (dysphemia) / stammering

    • (2022): Nikvarz N+, World J Psychiatry 12(2), 236-263 [REVIEW]

Suicidal ideation

    • (2014): Kemp DE, J Affect Disord 169 Suppl 1, S34 [REVIEW]

Hepatotoxicity / liver injury / acute liver injury / drug-induced liver injury (DILI)

    • (2022): Devarbhavi H+, Dig Dis Sci Dec, Online ahead of print (133 cases)

Coagulopathy / coagulation dysfunction / clotting factor deficiency (includes disseminated intravascular coagulation / DIC)

    • (2025): Mansoor A+, Drugs Real World Outcomes Mar (e-Collection) [REVIEW]

Downbeat nystagmus

    • (2015): Wu D+, Epilepsy Behav Case Rep 4, 74-5 (2 cases) [REVIEW]

Saved Searches Watched Drugs
Litt's app available free to subscribers

Search drug eruptions and reactions data anytime, anywhere

With full access to drug profiles, reactions and linked PubMed abstracts through your smart phone!

If you subscribe via your institution and do not have a personal login you will need to register on the website to create a login for the app.

Back to top
  • Help
  • Terms & Conditions
  • Privacy
  • Disclaimer
  • Contact us

© 2025 Taylor & Francis Group, LLC. All Rights Reserved.